Literature DB >> 28707106

Robotic transanal surgery (RTAS) with utilization of a next-generation single-port system: a cadaveric feasibility study.

J Marks1,2, S Ng3, T Mak3.   

Abstract

PURPOSE: Transanal surgery remains both an innovative approach to rectal pathology and a demonstrated technical challenge. Improved technology using a single-port system robotic platform (SPS) offers a promising option for this surgery.
METHODS: SPS robotic system was utilized to perform submucosal, full-thickness and cylindrical excision on four cadavers. Operative performance and surgeon fatigue were measured.
RESULTS: On all types of resections, the SPS system performed well. There were no piecemeal or fragmented resections. Closure was judged to be good to excellent in all cases. Surgeon assessment of setup and performance of the SPS was excellent in all cases.
CONCLUSIONS: SPS robotic transanal surgery represents an exciting new option for transanal surgery.

Entities:  

Keywords:  Robotic TEM (RTEM); Robotic transanal surgery (RTAS); Single port surgery (SPS); Transanal endoscopic surgery (TEM); Transanal minimally invasive surgery (TAMIS)

Mesh:

Year:  2017        PMID: 28707106     DOI: 10.1007/s10151-017-1655-3

Source DB:  PubMed          Journal:  Tech Coloproctol        ISSN: 1123-6337            Impact factor:   3.781


  9 in total

1.  Transanal endoscopic microsurgery.

Authors:  G F Buess; H Raestrup
Journal:  Surg Oncol Clin N Am       Date:  2001-07       Impact factor: 3.495

2.  Excision of a rectal neoplasm using robotic transanal surgery (RTS): a description of the technique.

Authors:  S Atallah; E Parra-Davila; T DeBeche-Adams; M Albert; S Larach
Journal:  Tech Coloproctol       Date:  2012-05-15       Impact factor: 3.781

3.  Transanal endoscopic microsurgery is more effective than traditional transanal excision for resection of rectal masses.

Authors:  Jesse S Moore; Peter A Cataldo; Turner Osler; Neil H Hyman
Journal:  Dis Colon Rectum       Date:  2008-05-15       Impact factor: 4.585

4.  Transanal TATA/TME: a case-matched study of taTME versus laparoscopic TME surgery for rectal cancer.

Authors:  J H Marks; G A Montenegro; J F Salem; M V Shields; G J Marks
Journal:  Tech Coloproctol       Date:  2016-05-13       Impact factor: 3.781

5.  Endoscopic surgery in the rectum.

Authors:  G Buess; R Theiss; M Günther; F Hutterer; H Pichlmaier
Journal:  Endoscopy       Date:  1985-01       Impact factor: 10.093

6.  A comparison of transanal excision and endoscopic resection for early rectal cancer.

Authors:  Soon Hak Lee; Seong Woo Jeon; Min Kyu Jung; Sung Kook Kim; Gyu Seog Choi
Journal:  World J Gastrointest Endosc       Date:  2009-10-15

7.  Transanal minimally invasive surgery (TAMIS) for local excision of benign neoplasms and early-stage rectal cancer: efficacy and outcomes in the first 50 patients.

Authors:  Matthew R Albert; Sam B Atallah; Teresa C deBeche-Adams; Seema Izfar; Sergio W Larach
Journal:  Dis Colon Rectum       Date:  2013-03       Impact factor: 4.585

8.  Transanal endoscopic microsurgery with entrance into the peritoneal cavity: is it safe?

Authors:  John H Marks; Joseph L Frenkel; Christopher E Greenleaf; Anthony P D'Andrea
Journal:  Dis Colon Rectum       Date:  2014-10       Impact factor: 4.585

9.  True NOTES TME resection with splenic flexure release, high ligation of IMA, and side-to-end hand-sewn coloanal anastomosis.

Authors:  John H Marks; Nicolas Lopez-Acevedo; Barath Krishnan; Matthew N Johnson; Grace A Montenegro; Gerald J Marks
Journal:  Surg Endosc       Date:  2016-01-28       Impact factor: 4.584

  9 in total
  10 in total

1.  Assessment of the Versius surgical robotic system for dual-field synchronous transanal total mesorectal excision (taTME) in a preclinical model: will tomorrow's surgical robots promise newfound options?

Authors:  S Atallah; E Parra-Davila; A G F Melani
Journal:  Tech Coloproctol       Date:  2019-05-08       Impact factor: 3.781

2.  Direct target NOTES: prospective applications for next generation robotic platforms.

Authors:  S Atallah; A Hodges; S W Larach
Journal:  Tech Coloproctol       Date:  2018-05-31       Impact factor: 3.781

3.  Review and update: robotic transanal surgery (RTAS).

Authors:  Melissa G Medina; Steven S Tsoraides; Anthony M Dwyer
Journal:  Updates Surg       Date:  2018-08-17

4.  First clinical experience with single-port robotic transanal minimally invasive surgery (SP rTAMIS) for benign rectal neoplasms.

Authors:  J H Marks; E Kunkel; J F Salem; C Martin; B Anderson; S Agarwal
Journal:  Tech Coloproctol       Date:  2020-10-17       Impact factor: 3.781

5.  Single-port robotic transanal minimally invasive surgery (SPR-TAMIS) approach to local excision of rectal tumors.

Authors:  S Liu; S R Kelley; K T Behm
Journal:  Tech Coloproctol       Date:  2020-07-06       Impact factor: 3.781

6.  Robotic transanal minimally invasive surgery (TAMIS) for local excision of rectal lesions with the da Vinci Xi (dVXi): technical considerations and video vignette.

Authors:  C D Warren; A E R Hamilton; A R L Stevenson
Journal:  Tech Coloproctol       Date:  2018-07-10       Impact factor: 3.781

7.  SP rTaTME: initial clinical experience with single-port robotic transanal total mesorectal excision (SP rTaTME).

Authors:  J H Marks; J F Salem; P Adams; T Sun; E Kunkel; H Schoonyoung; S Agarwal
Journal:  Tech Coloproctol       Date:  2021-04-21       Impact factor: 3.781

Review 8.  Locally Advanced Rectal Cancer: What We Learned in the Last Two Decades and the Future Perspectives.

Authors:  Vivek Srivastava; Aakansha Giri Goswami; Somprakas Basu; Vijay Kumar Shukla
Journal:  J Gastrointest Cancer       Date:  2022-01-03

9.  Single-port robotic left colectomy: first clinical experience using the SP robot (rSILS).

Authors:  J H Marks; J F Salem; B K Anderson; J M Josse; H P Schoonyoung
Journal:  Tech Coloproctol       Date:  2019-12-12       Impact factor: 3.781

10.  Da Vinci Single-Port robot-assisted transanal mesorectal excision: a promising preclinical experience.

Authors:  Werner Kneist; Hubert Stein; Markus Rheinwald
Journal:  Surg Endosc       Date:  2020-05-11       Impact factor: 4.584

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.